Floatz logo

Therapeutic Asset Ratings

191 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Brivaracetam
Alzheimer Disease
University of California, Los AngelesP1/2CC (41)
CellREADY®
Alzheimer Disease
University Hospital, ToulouseP1/2CC (41)
E22W mutant amyloid-beta peptide
Alzheimer Disease
Alzamend Neuro, Inc.P1/2CC (41)
ivl3003
Alzheimer Disease
Inventage Lab., Inc.P1/2CC (41)
nsc001
Alzheimer Disease
NSC-TherapeuticsP1/2CC (41)
Salicylamine acetate
Alzheimer Disease
MTI Biotech IncP1/2CC (41)
AIR
Alzheimer Disease
University of California, San DiegoP1CC (40)
Alia-1758
Alzheimer Disease
AbbVieP1CC (40)
Alz-101
Alzheimer Disease
Alzinova ABP1CC (40)
av-1959r
Alzheimer Disease
Nuravax, Inc.P1CC (40)
cms121
Alzheimer Disease
Virogenics, Inc.P1CC (40)
GB-5001
Alzheimer Disease
G2GBio, Inc.P1CC (40)
LISPRO-PH20 COMPONENT RHUPH20
Alzheimer Disease
Acumen PharmaceuticalsP1CC (40)
NH280105
Alzheimer Disease
Jiangsu Nhwa Pharmaceutical Co., Ltd.P1CC (40)
Oxygen
Alzheimer Disease
University of California, San DiegoP1CC (40)
vg-3927
Alzheimer Disease
Vigil Neuroscience, Inc.P1CC (40)
[ 18f]3f4ap
Alzheimer Disease
Yale UniversityP1C (37)
18F-NAV-4694
Alzheimer Disease
Tharick PascoalP1C (37)
ac-1202
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-010
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-02
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-03
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-04
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-05
Alzheimer Disease
CerecinP1C (37)
Ac-Ole-06
Alzheimer Disease
CerecinP1C (37)
Showing 126 to 150 of 191 assets
PreviousPage 6 of 8Next